Synthetic biology square-off

This weekend, 59 teams of undergraduates will be descending on Cambridge, Mass., for the 4th annual International Genetically Engineered Machines competition, aka the linkurl:iGEM Jamoboree.;http://parts.mit.edu/r/parts/igem/index.cgi I'm heading up there tomorrow to blog the event live. The event is a synthetic biology contest that grew out of a short course held at MIT in 2003. Students - mostly undergrads - spend the summer designing and building genetic machines from a standard set of biolo

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This weekend, 59 teams of undergraduates will be descending on Cambridge, Mass., for the 4th annual International Genetically Engineered Machines competition, aka the linkurl:iGEM Jamoboree.;http://parts.mit.edu/r/parts/igem/index.cgi I'm heading up there tomorrow to blog the event live. The event is a synthetic biology contest that grew out of a short course held at MIT in 2003. Students - mostly undergrads - spend the summer designing and building genetic machines from a standard set of biological parts called "biobricks." Last year's winners, from the University of Ljubljana in Slovenia, engineered cells that fight sepsis. This year, the Ljubljana team is back, with a synthetic antiviral defense system against HIV. Check in this weekend for updates as the judges poke and prod that project and others, such as learning-enabled E. coli and microbes with metabolisms tweaked to produce biofuels.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies